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A Prospective Evaluation of Survivorship of
Asymptomatic Degenerative Rotator Cuff Tears
Jay D. Keener, MD, Leesa M. Galatz, MD, Sharlene A. Teefey, MD, William D. Middleton, MD, Karen Steger-May, BA,
Georgia Stobbs-Cucchi, RN, Rebecca Patton, MA, and Ken Yamaguchi, MD
Investigation performed at the Shoulder and Elbow Service, Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri

Background: The purpose of this prospective study was to report the long-term risks of rotator cuff tear enlargement and
symptom progression associated with degenerative asymptomatic tears.
Methods: Subjects with an asymptomatic rotator cuff tear in one shoulder and pain due to rotator cuff disease in the
contralateral shoulder enrolled as part of a prospective longitudinal study. Two hundred and twenty-four subjects (118
initial full-thickness tears, ﬁfty-six initial partial-thickness tears, and ﬁfty controls) were followed for a median of 5.1 years.
Validated functional shoulder scores were calculated (visual analog pain scale, American Shoulder and Elbow Surgeons
[ASES], and simple shoulder test [SST] scores). Subjects were followed annually with shoulder ultrasonography and
clinical evaluations.
Results: Tear enlargement was seen in 49% of the shoulders, and the median time to enlargement was 2.8 years. The
occurrence of tear-enlargement events was inﬂuenced by the severity of the ﬁnal tear type, with enlargement of 61% of the
full-thickness tears, 44% of the partial-thickness tears, and 14% of the controls (p < 0.05). Subject age and sex were not
related to tear enlargement. One hundred subjects (46%) developed new pain. The ﬁnal tear type was associated with a
greater risk of pain development, with the new pain developing in 28% of the controls, 46% of the shoulders with a partialthickness tear, and 50% of those with a full-thickness tear (p < 0.05). The presence of tear enlargement was associated with
the onset of new pain (p < 0.05). Progressive degenerative changes of the supraspinatus muscle were associated with tear
enlargement, with supraspinatus muscle degeneration increasing in 4% of the shoulders with a stable tear compared with
30% of the shoulders with tear enlargement (p < 0.05). Nine percent of the shoulders with a stable tear showed increased
infraspinatus muscle degeneration compared with 28% of those in which the tear had enlarged (p = 0.07).
Conclusions: This study demonstrates the progressive nature of degenerative rotator cuff disease. The risk of tear
enlargement and progression of muscle degeneration is greater for shoulders with a full-thickness tear, and tear
enlargement is associated with a greater risk of pain development across all tear types.
Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.

Peer Review: This article was reviewed by the Editor-in-Chief and one Deputy Editor, and it underwent blinded review by two or more outside experts. It was also reviewed
by an expert in methodology and statistics. The Deputy Editor reviewed each revision of the article, and it underwent a ﬁnal review by the Editor-in-Chief prior to publication.
Final corrections and clariﬁcations occurred during one or more exchanges between the author(s) and copyeditors.

Q

uantifying the risk and rate of rotator cuff tear progression is of fundamental importance for formulating
appropriate surgical indications. Despite numerous
reports pertaining to the prevalence of asymptomatic rotator
cuff tears1-7, we are not aware of any long-term longitudinal

studies deﬁning the natural history of degenerative rotator cuff
tears. Previous studies have suggested the progressive nature of
degenerative rotator cuff tears in both asymptomatic and painful
shoulders8-12; however, these studies were often retrospective
with short-term follow-up.

Disclosure: One or more of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in
support of an aspect of this work. In addition, one or more of the authors, or his or her institution, has had a ﬁnancial relationship, in the thirty-six months
prior to submission of this work, with an entity in the biomedical arena that could be perceived to inﬂuence or have the potential to inﬂuence what is written
in this work. Also, one or more of the authors has had another relationship, or has engaged in another activity, that could be perceived to inﬂuence or have
the potential to inﬂuence what is written in this work. The complete Disclosures of Potential Conﬂicts of Interest submitted by authors are always
provided with the online version of the article.
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TABLE I Baseline and Final Tear Types in the Study Cohort (N = 219)*
Tear Type at Baseline
Control

Partial-Thickness

Full-Thickness

Total

Final tear type
Control
Partial-thickness
Full-thickness
Total

36

0

0

36

9

45

0

54

5

11

113

129

50

56

113

219

*Baseline tear types were reclassiﬁed to a new, ﬁnal tear type when a control was converted to a partial or full-thickness tear or a partial-thickness
tear was converted to a full-thickness tear during the follow-up period.

The indications for the surgical treatment of rotator cuff
tears have varied widely 13. Early surgical intervention for
painful tears is intended to prevent the tear enlargement and
muscle degeneration that can occur with nonoperative treatment as well as the diminished potential for tendon healing
with delayed surgery14-19. A more thorough understanding of
the natural history of rotator cuff disease can increase the
ability to identify patients and shoulders at risk for disease

progression and reﬁne surgical indications. Furthermore, patients can be more effectively counseled regarding the potential
risks of nonoperative treatment. Although recent studies have
improved our understanding of the evolution of rotator cuff
disease8-11, many questions remain unanswered.
Accurate characterization of the natural history of degenerative cuff disease requires a well-controlled prospective
longitudinal follow-up study design with well-deﬁned end

ä

TABLE II Demographics and Baseline Characteristics of the Study Cohort

Variable (Baseline)

Entire Cohort (N = 224*)

Control (N = 50*)

Partial-Thickness
Tear (N = 56*)

60.7 ± 10

59.4 ± 10

Age† (yr)

62.0 ± 10

Female sex (no. [%])

92 (41%)

22 (44%)

26 (46%)

Dominant side asymptomatic (no. [%])

81 (36%)

14 (28%)

17 (30%)

Full-thickness tear size (no.)
Tear length‡ (mm)

Not applic.

Not applic.

6.0 (2.5)

Tear width‡ (mm)

Not applic.

Not applic.

9.0 (4.0)

(mm2)

Not applic.

Not applic.

64.0 (49)

Supraspinatus
Infraspinatus

13/162 (8%)
11/163 (7%)

1/46 (2%)
1/46 (2%)

0/36 (0%)
0/37 (0%)

Supraspinatus or infraspinatus

16/162 (10%)

1/46 (2%)

0/36 (0%)

Tear area‡

Muscle degeneration§ (no. [%])

VAS pain score‡
ASES score‡ (points)

1.0 (0)
98.3 (10), n = 223

1.0 (0)
100 (0)

1.0 (0)
98.3 (10)

SST score‡ (points)

91.7 (27), n = 218

100 (0)

91.7 (33)

Elevation strength† (N)

55.8 ± 28, n = 115

58.3 ± 27

55.4 ± 28

External rotation strength† (N)

68.8 ± 32, n = 220

70.7 ± 26

73.5 ± 33

*When data were available for less than the entire cohort, the sample size (n) or the denominator is also provided. †The values are given as the
mean and standard deviation. ‡The values are given as the median with the interquartile range in parentheses. §Fatty inﬁltration was identiﬁed by
rating architecture and echogenicity on a 0 to 2-point scale and summing the two scores. Values of >0 indicate the presence of fatty inﬁltration.
#Analysis of variance was used to compare the tear-type groups and, when the overall model was signiﬁcant (p < 0.05), Tukey-adjusted pairwise
comparisons were performed. **The analysis was performed with use of rank-transformed data. ††The analysis was performed with the Fisher
exact test.
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points, particularly since the factors related to tear progression
and the relationships of tear progression to pain development
have not been clearly deﬁned. Asymptomatic degenerative
rotator cuff tears represent an ideal cohort for studying the
natural history of cuff disease, as clinical intervention is not
necessitated by pain, and the recognized potential for later
symptomatic change8,9 suggests an appropriate model. The
purpose of this study was to report the risk of symptom development, tear size progression, and muscle degeneration in a
cohort of subjects with an asymptomatic rotator cuff tear and
analyze factors associated with these changes.
Materials and Methods

O

ur university institutional review board approved this study. This study
cohort consisted of subjects with an asymptomatic rotator cuff tear who
presented for evaluation of shoulder pain secondary to rotator cuff disease in
8
the contralateral shoulder . All subjects had physical ﬁndings in the painful
shoulder that were consistent with rotator-cuff-based pain and nearly all had an
ultrasound-proven cuff tear in the painful shoulder. Inclusion criteria were (1)
bilateral shoulder ultrasonography performed to investigate unilateral shoulder
pain, (2) painful rotator cuff disease in the symptomatic shoulder, (3) a rotator
cuff tear in the asymptomatic shoulder at the time of study enrollment, and (4)
no history of trauma to either shoulder and no traumatic episode throughout
the study period. Control subjects with no ultrasound evidence of a rotator cuff

A P R O S P E C T I V E E VA LUAT I O N O F S U R V I VO R S H I P
D E G E N E R AT I V E R O TAT O R C U F F T E A R S
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tear in one shoulder and painful cuff disease in the contralateral shoulder were
also enrolled during the same time period. Exclusion criteria were (1) any past
or current pain in the “asymptomatic” shoulder, (2) continuous use of narcotic
or nonsteroidal anti-inﬂammatory drugs (NSAIDs) in the three months prior
to enrollment, (3) a traumatic episode affecting the asymptomatic shoulder,
(4) inﬂammatory arthritis, (5) radiographic evidence of osteoarthritis in the
asymptomatic shoulder, (6) upper-extremity weight-bearing demands, (7) a
subscapularis tendon tear in the asymptomatic shoulder, and (8) a very small
(<5 mm) partial-thickness tear in the asymptomatic shoulder.

Study Protocol
Subjects were enrolled from the clinical practices of three surgeons over a thirtymonth period. A priori power calculations were performed to determine the
sample size needed for acceptably precise estimated rates of tear enlargement and
pain development in shoulders with an asymptomatic tear. With an enrollment of
265 subjects, a 30% dropout rate (185 subjects providing data), and the assumption that 39% of the subjects would experience tear enlargement during the
20
follow-up periord , the 95% conﬁdence bounds around the estimated enlargement rate ranged from 32% to 46%, meaning that the estimates would be within
7% of the true value. With these assumptions, the sample size provided enlargement estimates within 8.5% and 11.5% of the true value for each group, respectively. Assuming that 51% of the subjects would develop pain, the target sample size
would again achieve 95% bounds with 7% of the true rate (44% to 58%).
A trained research nurse performed a comprehensive physical examination of the asymptomatic shoulder consisting of goniometric assessment of
its active range of motion. Assessment of isometric shoulder elevation strength

TABLE II (continued)
P Value
Full-Thickness Tear (N = 118*)

Comparison Across
Tear Groups

Control Vs.
Full-Thickness

Partial Vs.
Full-Thickness

<0.05

<0.05

Control Vs.
Partial-Thickness

63.8 ± 9
44 (37%)
50 (42%)
31 small, 74 medium, 10 large, 3 massive
11.0 (8.0), n = 114
10.0 (7.0), n = 113
108 (164), n = 111

<0.05#**
0.052#**
<0.05#**

12/80 (15%)

<0.05††

10/80 (13%)

<0.05††

15/80 (19%)

<0.05††

1.0 (0)

0.055
<0.05

<0.05
<0.05

0.30#**

96.3 (12)

<0.05#**

<0.05

87.1 (33)

<0.05#**

<0.05

53.3 ± 29

0.71#

65.7 ± 34

0.30#

0.05
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TABLE III Risk Factors for Tear Progression*

Risk Factor

No Enlargement
(N = 111)

Enlargement (N = 108)

Tear type‡

P Value from Cox Regression for Enlargement†
P < 0.05
Full vs. control: p < 0.05, HR = 4.17
Partial vs. control: p < 0.05, HR = 2.73
Full vs. partial: p = 0.07, HR = 1.53

Control

31 (86%)

5 (14%), time to enlargement:
median, 2.2 yr (IQR, 1.7)

Partial-thickness

30 (56%)

24 (44%), time to enlargement:
median, 3.3 yr (IQR, 3.1)

Full-thickness

50 (39%)

79 (61%), time to enlargement:
median, 2.3 yr (IQR, 3.7)

62.4 ± 10

61.4 ± 10

Male

61 (48%)

67 (52%)

Female

50 (55%)

41 (45%)

No

82 (58%)

59 (42%)

Yes

29 (37%)

49 (63%)

Mean baseline age (±SD) (yr)
Sex‡

HR = 0.99 (0.97-1.01)§

Study side dominant‡

P < 0.05, HR = 1.53

Smoking status‡

Previous vs. never: HR = 0.97 (0.65-1.45)§
Current vs. never: HR = 0.90 (0.39-2.09)§

Never

59 (48%)

63 (52%)

Previous
Current

41 (51%)
11 (65%)

39 (49%)
6 (35%)

*Five massive tears were excluded from the analysis because they were too large for enlargement to be documented accurately. †HR = hazard
ratio. The numbers in parentheses after the hazard ratios represent the 95% conﬁdence intervals for the hazard ratios. ‡The values are given as the
number of subjects with the percentage of the risk-factor group in parentheses. §A p value was not assigned because of a lack of power analysis
for the variable.

(90° elevation in the scapular plane) and external rotation strength (with the
shoulder adducted and in neutral rotation) was performed with an IsoBex
dynamometer (Medical Device Solutions, Oberburg, Switzerland), with the
ﬁnal measurement the average of three repetitions.
Patient questionnaires consisting of a visual analog scale (VAS) ranging
from 0 to 10 to rate average daily pain with use of whole integers, the American
Shoulder and Elbow Surgeons (ASES) score, and the simple shoulder test (SST)
with the score normalized to 100 points were completed. The patient was
assessed for shoulder pain at study enrollment and during longitudinal followup, with the deﬁnition of pain consisting of any of the following: (1) shoulder
pain ‡3 on the 10-point scale lasting six weeks or longer, (2) pain greater than
that experienced as a part of daily living, (3) pain requiring narcotic or NSAID
medications, (4) pain prompting evaluation by a physician, and (5) night pain
affecting sleep. Annual (plus or minus three months) examinations were performed with all components of the initial evaluation repeated, including ultrasonography. Subjects were asked to contact the study coordinator if new
shoulder pain developed between visits, and this prompted immediate repeat
evaluation. Subjects were retained for ongoing evaluation regardless of pain
development or tear enlargement.

Shoulder Ultrasonography and Tear Enlargement Criteria
Each subject underwent a standardized shoulder ultrasound study (see
21,22
Appendix)
. The maximum anteroposterior dimension of the tear was
measured on transverse views (perpendicular to the long axis of the cuff)
and designated as the tear width. The maximum degree of retraction was

measured on longitudinal views (parallel to the long axis of the cuff) and
designated as the tear length. Tear length was measured from the tendon
defect to the lateral edge of the normal tendon footprint on the greater
tuberosity. In this study, “tear type” refers to the control, partial-thicknesstear, or full-thickness-tear category.
Tear enlargement was determined on the basis of sequential annual
ultrasound reports. A full-thickness cuff tear was considered to have enlarged if
its size had increased by ‡5 mm in any dimension compared with baseline. Five
millimeters was chosen to account for the inherent variability in the accuracy of
22
ultrasonography and to represent clinically meaningful enlargement. If the
change in tear dimension met the criterion for enlargement but was a borderline value, subsequent ultrasound studies were reviewed to conﬁrm that the
size change was consistent with that seen on the previous ultrasound study. If
the subsequent value did not conﬁrm an increase from baseline values, the tear
was not considered to have enlarged. Once a tear was conﬁrmed to have enlarged, the new tear size was set as the new baseline for future comparisons. A
partial-thickness tear was considered to have enlarged when it had converted to
a full-thickness defect, deﬁned as a complete disruption of tendon continuity at
the insertion. In the control shoulders, enlargement was deﬁned as the development of a partial or full-thickness defect of at least 5 mm in any dimension.
Tear-size values were also analyzed to identify a decrease in size over time. A tear
was considered to be smaller when a decrease of ‡5 mm in any dimension was
identiﬁed and was corroborated on subsequent ultrasound examinations. Five
subjects who had a massive tear that was too large to accurately measure at
baseline were excluded from the tear-enlargement analysis.
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TABLE IV Association Between Final Tear Type and the Development of Pain
Final Tear Type*
Variable

Control (N = 36)

New pain

10 (28%)

Remained asymptomatic (ref.)

26 (72%)

Full-Thickness (N = 129)

P Value from CochranArmitage Trend Test

25 (46%)

65 (50%)

<0.05

29 (54%)

64 (50%)

Partial-Thickness (N = 54)

*The values are given as the number of subjects with the percentage of the tear-type group in parentheses.

Tear enlargement was deﬁned as a change in the tear type or an increase
in the size from baseline values. Once a tear progressed into a more advanced
category (from control to partial or from partial to full), that tear was included
in the more advanced group (now deﬁned as the ﬁnal tear type) for further
monitoring of pain development (Table I).

Summary data for normally distributed variables are presented as the
mean and standard deviation (SD), and data for variables that are not normally
distributed are presented as the median and interquartile range (IQR). Categorical variables are presented as the number of subjects and the percentage of
the speciﬁed group. P values of <0.05 were considered signiﬁcant.

Statistical Analysis

Source of Funding

Categorical baseline characteristics were compared across baseline tear groups
with use of the Fisher exact test. Continuous baseline characteristics were
compared with analysis of variance followed by Tukey-adjusted post-hoc
pairwise comparisons between tear groups. Variables that were not normally
distributed were rank-transformed prior to analysis. To account for different
durations of follow-up, separate univariable Cox proportional hazard regression models were used to determine if the risk factors for new pain development or degenerative rotator cuff muscle changes were associated with the time
between study entry and the occurrence of tear enlargement. Subjects with a
stable tear who underwent surgery were censored at the time of surgery, and
subjects with a stable tear who were lost to follow-up were censored at their
ﬁnal visit. Hazard regression analysis was used to examine the association of
demographic variables, tear type, new pain development, and progression of
muscle degeneration with tear enlargement. The reference group for the hazard
regression analysis for each categorical risk factor was the group of patients
without the risk factor. Hazard regression analysis for continuous risk factors is
expressed for a one-unit increase in the risk factor.
Without regard for the temporal relationship of events, the CochranArmitage trend test was used to determine if advancing category of ﬁnal tear
type was associated with new pain development. A Cox model was used to
determine if the occurrence of tear enlargement was associated with the time
between study entry and new pain development.
Kaplan-Meier survival curves were generated to describe the annual rate
at which (1) tear enlargement occurred according to tear type and (2) new pain
occurred. Annual survival rates are reported for the time between study entry
and the outcome at each follow-up point through year ﬁve.
For patients who developed pain before the occurrence of tear enlargement, an unpaired t test or the Wilcoxon signed rank test was performed to
determine if a change in function occurred between baseline and the ﬁrst
occurrence of pain.

The study was funded by the National Institutes of Health (R01 AR051026).

Results
Baseline Demographics
wo hundred and ﬁfty subjects were enrolled, and twentysix of them were lost to follow-up or later excluded during
the study. Of the 224 subjects who remained, 118 (53%) had a
full-thickness tear, ﬁfty-six (25%) had a partial-thickness tears,
and ﬁfty (22%) were control subjects. The age and sex distributions were similar among the baseline tear types (Table II).
At baseline, the full-thickness tears were signiﬁcantly larger
than the partial-thickness tears (median, 11.0 mm versus
6.0 mm, p < 0.05) and signiﬁcantly larger in area (p < 0.05);
however, the difference in tear width did not reach signiﬁcance
(median, 10.0 mm versus 9.0 mm, p = 0.052). A greater proportion of full-thickness tears were associated with degenerative changes in the supraspinatus (p < 0.05) and infraspinatus
(p < 0.05) muscles. Baseline SST (p < 0.05) and ASES (p <
0.05) scores worsened with advancing tear type; however, no
signiﬁcant differences were seen in baseline pain scores or
strength among the tear groups.

T

Tear Progression
The median duration of follow-up was 5.1 years (range, 0.3 to
10.0 years). The median duration of study inclusion was longer
for the tears that enlarged (5.9 years) than for the stable tears

TABLE V Association Between Development of New Pain and Tear Enlargement

Variable

No Enlargement*
(N = 111)

Enlargement* (N = 108)

New pain

37 (37%)

63 (63%): 41 at/before 1st enlargement,
22 after 1st enlargement

Remained asymptomatic (ref.)

74 (62%)

45 (38%)

P Value from Cox Regression
for Enlargement†
P < 0.05, HR = 1.66

*The values are given as the number of subjects with the percentage of the pain group in parentheses. †HR = hazard ratio.
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TABLE VI Association Between Degenerative Rotator Cuff Muscle Changes and Tear Enlargement
No Enlargement*
(N = 77)

Enlargement*
(N = 82)

No (ref.)

74 (96%)

57 (70%)

Yes
Infraspinatus

3 (4%)

25 (30%)

No (ref.)

70 (91%)

59 (72%)

7 (9%)

23 (28%)

69 (90%)

47 (57%)

8 (10%)

35 (43%)

Variable

P Value from Cox Regression
for Enlargement†

Increased muscle degeneration
Supraspinatus

<0.05, HR = 2.00

0.07

Yes
Supraspinatus or infraspinatus
No (ref.)
Yes

<0.05, HR = 1.91

*The values are given as the number of subjects with the percentage of the no-enlargement or enlargement group in parentheses. †HR = hazard ratio.

(4.9 years, p < 0.05). Tear progression was seen in 49% of the
shoulders, and the median time to enlargement was 2.8 years.
The risk of tear enlargement was signiﬁcantly inﬂuenced by the
severity of the ﬁnal tear type (Table III), with tear-enlargement
rates of 61% in the full-thickness-tear group, 44% in the partialthickness-tear group, and 14% in the control group (p < 0.05).
Cox regression analysis showed the risk of enlargement in the
full-thickness-tear group to be 4.2 times greater than that in the
control group and 1.5 times larger than that in the partial-

thickness-tear group. Three partial-thickness and six fullthickness tears decreased in size compared with baseline. Four
of these tears (all full-thickness) later enlarged compared with
the original values.
If the study shoulder was the dominant extremity, there
was a greater likelihood of tear enlargement (63% in dominant
shoulders compared with 42% in nondominant shoulders, p <
0.05). We found no clinically relevant differences in age, sex, or
smoking status between stable and enlarged tears.

Fig. 1

Kaplan-Meier annual survival curves for tear enlargement by ﬁnal tear type.
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TABLE VII Changes in Function Between Baseline and the Onset of New Pain

Visit*

Entire Cohort (N = 80: 10 Controls,
20 Partial-Thickness Tears,
50 Full-Thickness Tears)

VAS score for pain (0 = no pain, 10 = incapacitating pain)‡

<0.05§

Baseline

1.0 (0.0)

1st occurrence of pain

5.0 (3.0)

Delta

3.0 (3.0)

SST‡
Baseline
1st occurrence of pain
Delta

<0.05
83.3 (34.8)
69.7 (33.3)
214.8 (33.2)

ASES‡
Baseline
1st occurrence of pain
Delta

<0.05
96.5 (11.7)
60.0 (26.5)
231.9 (27.0)

External rotation strength# (N)
Baseline
1st occurrence of pain
Delta

<0.05
68.4 ± 34
58.2 ± 30
210.2 ± 25

Elevation strength# (N)
Baseline
1st occurrence of pain
Delta

<0.05
55.4 ± 26
33.3 ± 20
222.1 ± 18

Forward elevation—active# (deg)
Baseline
1st occurrence of pain
Delta

<0.05§
154 ± 14
145 ± 20
29.2 ± 25

External rotation at 90°—active# (deg)
Baseline

<0.05
91.1 ± 12

1st occurrence of pain

82.2 ± 13

Delta

28.9 ± 16

Internal rotation in abduction—active# (deg)

0.24

Baseline
1st occurrence of pain

65.9 ± 20
62.7 ± 17

Delta

23.2 ± 24

External rotation with arm at side—active# (deg)
Baseline

P Value†

<0.05
72.4 ± 18

1st occurrence of pain

62.8 ± 14

Delta

29.6 ± 23

*Delta for each patient was calculated by subtracting the baseline value from the value at the ﬁrst occurrence of pain. The average time between
these visits was 987 ± 705 days (range, 161 to 2881 days). †The p values were derived by comparing delta with zero in paired t tests unless
otherwise indicated. ‡The values are given as the median with the interquartile range in parentheses. §The p value was derived with the Wilcoxon
signed rank test. #The values are given as the mean and standard deviation.

Survivorship Analysis
The median time to enlargement was 2.2, 3.3, and 2.3 years for
the control, partial-thickness, and full-thickness groups, respectively. Figure 1 shows the ﬁve-year survivorship of the three
groups with tear enlargement as the end point. Survivorship

was 100% at one and two years, 90% at three years, 86% at four
years, and 81% at ﬁve years in the control group. The yearly
survivorship values (for years one through ﬁve) were 94%,
89%, 80%, 71%, and 65% in the partial-thickness group and
95%, 78%, 66%, 57%, and 50% in the full-thickness group.
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Symptom Progression
One hundred shoulders (46%) developed new pain (Table IV).
The median time to pain development was 2.6 years. In the
entire cohort, the annual survivorship values (for years one
through ﬁve) with the development of new pain as the end
point were 94%, 82%, 72%, 63%, and 56%. A greater risk for
pain development was associated with a more advanced ﬁnal
tear type (p < 0.05). Twenty-eight percent of the controls, 46%
of the patients with a partial-thickness tear, and 50% of those
with a full-thickness tear developed new pain.
Tear enlargement was a signiﬁcant risk factor for the
development of shoulder pain (p < 0.05) (Table V). The tear
enlarged in 38% of the shoulders that remained asymptomatic
compared with 63% of those that developed pain. Cox regression analysis demonstrated a 1.66 times higher prevalence
of tear enlargement in shoulders that developed pain compared
with shoulders that remained asymptomatic. There was a 1.69
times higher prevalence of new pain in the shoulders in which
the tear enlarged compared with the shoulders with a stable
tear (p < 0.05). Of the sixty-three shoulders in which the tear
enlarged and became painful, forty-one became painful at or
before the time of the initial enlargement and twenty-two, at a
later time point.
Muscle Degenerative Changes
Complete assessment of muscle degenerative changes was done
for 159 shoulders. Tear enlargement was signiﬁcantly associated with progressive degenerative changes in the supraspinatus muscle (Table VI). Four percent of the stable tears were
associated with an increase in supraspinatus degeneration (of at
least one grade) compared with 30% of the tears that enlarged
(p < 0.05). Nine percent of the shoulders with a stable tear
showed an increase in infraspinatus degeneration compared
with 28% of the shoulders with tear enlargement (p = 0.07).
Shoulder Function
Nearly all shoulders with new pain showed a signiﬁcant decline
in function from baseline values (Table VII). The median VAS
pain score increased by 3.0 points (p < 0.05), and the median
ASES and SST scores decreased by 31.9 (p < 0.05) and 14.8 (p <
0.05) points, respectively.
Discussion
he results of this prospective longitudinal study demonstrated a high risk of rotator cuff tear enlargement over a
relatively short time period. The most clinically relevant relationship was between a greater risk of tear progression and a
more severe tear type. Full-thickness tears were 4.2 times and
1.5 times more likely to enlarge than controls and partialthickness tears, respectively. Our data suggest that activity level
may inﬂuence tear progression given the higher rate of enlargement seen in dominant shoulders. We found a greater risk
of pain development in shoulders in which the tear enlarged
compared with those in which the tear remained stable.
Natural history studies are important for deﬁning the
risks and rates of disease progression over time, and they allow
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better assessment of the appropriate timing of intervention
and identiﬁcation of speciﬁc at-risk groups in which early
intervention may be most beneﬁcial. Natural history information about degenerative rotator cuff disease is lacking in
comparison with the large volume of data dedicated to the
outcomes of various treatments, usually surgical intervention.
Repeated longitudinal assessments provide clearer estimates
of the timeline for tear progression and allow closer monitoring of symptom progression and subsequent changes in
shoulder function.
The rate of progression of asymptomatic cuff tears in this
study is similar to rates in two previous studies of conservatively treated painful cuff tears10,11. Using ultrasound and similar deﬁnitions of tear enlargement, Safran et al. showed that
49% of painful full-thickness cuff tears enlarged after a mean of
twenty-nine months of follow-up11. Maman et al. examined
tear progression with magnetic resonance imaging (MRI) and
noted that 48% of painful tears reexamined at more than
eighteen months had enlarged compared with 19% of tears
followed for less than eighteen months10. Similar to our ﬁndings, the risk of progression was lower for partial-thickness
tears than for full-thickness tears10. The increased risk of progression of full-thickness tears highlights the need for either
close surveillance or surgical intervention for painful shoulders
in this higher-risk group.
The relatively low prevalence of muscle degeneration in
our study may be a reﬂection of the small size of the typical fullthickness tear in this cohort. Nevertheless, the results demonstrated that progressive muscle degeneration is associated
with progression of even smaller tears. In two previous studies,
no correlation was seen between enlargement of painful tears
and progression of muscle degeneration, although trends were
evident10,12. In both series the number of subjects, particularly
those who developed atrophy, was small. It is likely that our
ﬁndings differ because of our larger cohort, longer follow-up
period, and prospective study design. The progression of
muscle degeneration is a very relevant consideration when
counseling subjects with an enlarging rotator cuff tear as both
factors are associated with lower rates of tendon healing following surgery.
The onset of pain was associated with a clinically meaningful decline in shoulder function based on established minimal clinically important differences for shoulder pain and the
ASES score; however, the decrease in the SST score was just
below the established minimal clinically important difference
for patients with rotator cuff disease23. A more severe tear type
was associated with a higher risk of pain development. We
chose to analyze the risk of pain development on the basis of
the ﬁnal tear type to more accurately reﬂect how these risks
change as a tear evolves. In our previous study of this cohort,
23% of the subjects developed new pain, which was related to
tear progression8. In the present study, we showed that tear
progression was a signiﬁcant risk factor for pain development,
noting an even stronger relationship than was seen in our
earlier study. These ﬁndings are similar to those in a recent
study by Moosmayer et al., in which 36% of the subjects with an
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asymptomatic full-thickness tear developed pain over the
course of short-term follow-up9. They also noted a greater
progression of tear size in shoulders that became painful. The
temporal relationship between enlargement and pain development warrants further analysis as pain occurred after the
identiﬁcation of initial tear enlargement in 35% of our patients
who had both enlargement and pain development. We believe
that the collective ﬁndings of these studies emphasize that
symptom progression should be carefully evaluated as a possible clinical sign of tear progression.
Our study had several limitations. Our subjects had
painful rotator cuff disease in the contralateral shoulder;
therefore, ﬁndings may differ from those in subjects with
unilateral disease. Nevertheless, we believe that the results of
this study may represent the natural history of symptomatic
cuff disease given the recognized bilateral nature of tears; our
cohort was a true at-risk population. Another limitation is that
the chronicity of the tears was unknown and it is possible that
unknown differences in disease duration can inﬂuence the rates
of tear progression and symptom development. Also, we did
not analyze the potential relationships of other variables, such
as occupation, medical comorbidities, and the tear size in the
contralateral shoulder, to the risks of tear progression and pain
development.
The evaluation of muscle degeneration may have been
biased as muscle evaluation was not performed in the earlier
part of the study. We began collecting muscle degeneration
data after ultrasound ﬁndings were validated through a
comparison with MRI ﬁndings24. Despite this shortcoming,
we were able to clearly demonstrate progression of supraspinatus degeneration and a trend toward progression of
infraspinatus degeneration in association with full-thickness
tears that enlarged.
The strengths of this study are primarily related to its
design, as it involved a large cohort of patients followed prospectively at well-deﬁned time intervals to allow better deﬁnition of time-dependent tear progression. Use of a control
group similar to the study group was an important reference
with which to compare risks of tear progression in shoulders
with tears. This study included a standardized and validated
annual evaluation performed by trained research nurses, and
radiologists conducted all ultrasound examinations to mini-
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mize observer bias. Strict deﬁnitions of tear enlargement and
symptom development were designated prior to study initiation. Finally, categorization of ﬁnal tear type better characterized the risks of tear progression and pain development as an
asymptomatic tear evolves over time.
In conclusion, this prospective, longitudinal study demonstrated the progressive nature of asymptomatic degenerative
rotator cuff tears in subjects with a contralateral symptomatic
rotator cuff tear. The risk of enlargement is greater for more
advanced tears, and tear enlargement is associated with a greater
risk of cuff muscle degeneration and of pain development. New
pain may be a clinical sign of tear progression.
Appendix
A detailed description of the ultrasound studies of the
rotator cuff tears and the evaluation of the fatty degeneration of the rotator cuff muscles is available with the online
version of this article as a data supplement at jbjs.org. n
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